Novo Nordisk Chief Scientific Officer Martin Holst Lange discusses the recent clinical trial results of the company's weight loss obesity shot CagriSema, which delivered less weight loss than Eli Lilly's tirzepatide. Holst Lange also outlines Novo Nordisk's broader obesity treatment pipeline. He speaks on "Bloomberg Open Interest."
Market reaction to the US Supreme Court ruling on tariffs has been subdued, said Bank of Montreal Chief Executive Officer Darryl White. "Part of that is because some of the outcome that we saw over the last few days was probably priced into bond markets, so we haven't seen much of a reaction there," he said on Bloomberg Surveillance.
Parts of New York City got up to 28 inches of snow during this blizzard, but most of the transit system is up and running. There are reduced schedules. MTA Chair and CEO Jano Lieber gives an update on Bloomberg Surveillance.
Federal Reserve Governor Christopher Waller said his decision on whether to support an interest-rate cut at the US central bank's next policy meeting on March 17-18 will depend on upcoming labor-market data. Waller spoke Monday at an event in Washington with the National Association for Business Economics
For decades, Harvard has sought to develop land in Boston's Allston neighborhood, looking to turn the area into a science hub with innovative labs that could spur local economic growth. Now a perfect storm is brewing, one tied to real estate, biotechnology and the Trump administration, that is blowing the university's ambitious plans off course.
"We will always be part of the M&A discussion," says Stéphane de La Faverie, CEO of The Estée Lauder Companies, as the company explores different strategies to rebuild profitability and regain market share. He spoke to Bloomberg's Francine Lacqua on "The Pulse."
Priya Misra, Core Plus Bond ETF portfolio manager at JPMorgan, says President Donald Trump's threat of using trade licenses to charge foreign countries after the Supreme Court struck down his global tariffs is "just reinforcing policy uncertainty" for markets.
"This 10% or 15%, it's not done," says Peter Tchir, head of macro strategy at Academy Securities, as he explains his market fears related to the Supreme Court striking down President Donald Trump's global tariffs.
The European Union is poised to halt the ratification process of its trade deal with the US as it awaits more details on the new tariff program from President Donald Trump's administration. Kasia Klimasinska reports on Bloomberg Television.
Ifo President Clemens Fuest discusses the outlook for German growth after business confidence brightened more than anticipated in February, adding to hope that Europe's largest economy is emerging from a yearslong malaise. An expectations index by the Ifo institute increased to 90.5 from a revised 89.6 in January, above the median estimate of 90 in a Bloomberg survey. Fuest speaks on Bloomberg Television.
Orange CEO Christel Heydemann said the French carrier and its partners have not yet reached an agreement on a new bid to buy rival SFR. She also speaks about the company's expansion plans, AI disruption and satellites. She spoke with Bloomberg's Anna Edwards, Tom Mackenzie and Guy Johnson.
Anna Edwards, Guy Johnson, Tom Mackenzie and Paul Dobson break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade." For up to the minute market intelligence and insight, click MLIV <GO>.
